Literature DB >> 19181316

ADMA and SDMA levels in healthy men exposed to tobacco smoke.

Andrzej Sobczak, Maciej Lukasz Goniewicz, Izabela Szoltysek-Boldys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19181316      PMCID： PMC2789676          DOI： 10.1016/j.atherosclerosis.2008.12.039

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  17 in total

1.  Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.

Authors:  Lydia A Bazzano; Jiang He; Paul Muntner; Suma Vupputuri; Paul K Whelton
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

2.  Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.

Authors:  Renate Schnabel; Stefan Blankenberg; Edith Lubos; Karl J Lackner; Hans J Rupprecht; Christine Espinola-Klein; Nicole Jachmann; Felix Post; Dirk Peetz; Christoph Bickel; François Cambien; Laurence Tiret; Thomas Münzel
Journal:  Circ Res       Date:  2005-08-11       Impact factor: 17.367

3.  Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?

Authors:  Serena Tonstad; Hege Thorsrud; Peter A Torjesen; Ingebjørg Seljeflot
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

4.  Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

Authors:  Andreas Meinitzer; Ursula Seelhorst; Britta Wellnitz; Gabriele Halwachs-Baumann; Bernhard O Boehm; Bernhard R Winkelmann; Winfried März
Journal:  Clin Chem       Date:  2006-12-21       Impact factor: 8.327

5.  Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.

Authors:  Hilde M A Eid; Harald Arnesen; Elsa M Hjerkinn; Torstein Lyberg; Ingebjørg Seljeflot
Journal:  Metabolism       Date:  2004-12       Impact factor: 8.694

6.  Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC.

Authors:  Tom Teerlink
Journal:  Methods Mol Med       Date:  2005

7.  Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.

Authors:  Renke Maas; Friedrich Schulze; Jens Baumert; Hannelore Löwel; Khatera Hamraz; Edzard Schwedhelm; Wolfgang Koenig; Rainer H Böger
Journal:  Clin Chem       Date:  2007-02-22       Impact factor: 8.327

8.  Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.

Authors:  R Schiel; S Franke; M Busch; A Müller; C Fleck; U A Müller; A Braun; G Stein
Journal:  Eur J Med Res       Date:  2003-07-31       Impact factor: 2.175

9.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

Authors:  P Vallance; A Leone; A Calver; J Collier; S Moncada
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

10.  Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.

Authors:  Tse-Min Lu; Yu-An Ding; Shing-Jong Lin; Wen-Shin Lee; Ho-Charng Tai
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983
View more
  3 in total

1.  Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.

Authors:  Mark G O'Doherty; Sarah E C M Gilchrist; Ian S Young; Michelle C McKinley; John W G Yarnell; K Fred Gey; Alun Evans; Paula M L Skidmore; Jayne V Woodside
Journal:  Eur J Nutr       Date:  2010-04-18       Impact factor: 5.614

2.  AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.

Authors:  Mina Amir; Sally I Hassanein; Mohamed F Abdel Rahman; Mohamed Z Gad
Journal:  Mol Biol Rep       Date:  2018-10-03       Impact factor: 2.316

Review 3.  Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

Authors:  Shufen Chen; Na Li; Milani Deb-Chatterji; Qiang Dong; Jan T Kielstein; Karin Weissenborn; Hans Worthmann
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.